Pharmaceutical
Ended Awarded Last action
- Contract number
- VA77016J1206
- Awardee
-
Acorda Therapeutics, Inc. UEI R5D3FUPFFPK4
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $478,860
Award facts
- Contract value 100% obligated
- $478,860.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Veterans Integrated Service Network 12 Veterans Health Administration, Department of Veterans Affairs
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Ardsley, NY 10502, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies. The contract, valued at $478,860.00, is a Firm Fixed Price Delivery Order under Acorda's Federal Supply Schedule (FSS) contract with the VA. The contract is for the supply of Levodopa 42mg inhalation capsules, a medication used to treat Parkinson's disease, to the VA's Veterans Health Administration and Veterans Integrated Service Network 12. The contract does not have a set-aside designation, indicating that Acorda competed on an unrestricted basis. Acorda Therapeutics also holds two Blanket Purchase Agreements (BPAs) with the VA National Acquisition Center, valued at $5.5 million and $7.5 million, for the procurement of its other neurological medications, Inbrija and Ampyra, which are used to manage Parkinson's disease and multiple sclerosis, respectively. These BPAs provide a streamlined process for VA medical facilities to order Acorda's products, supporting the agency's mission to provide quality healthcare to veterans.
Quick answers
Who was awarded contract VA77016J1206?
VA77016J1206 was awarded to Acorda Therapeutics, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on June 14, 2016.
How much is contract VA77016J1206 worth?
The government has obligated $478,860 on VA77016J1206.
Which agency awarded contract VA77016J1206?
Veterans Integrated Service Network 15 (Veterans Health Administration) awarded VA77016J1206, with funding from Veterans Integrated Service Network 12 (Veterans Health Administration).
Is contract VA77016J1206 an order under another contract?
Yes. VA77016J1206 is a delivery order under V797P5233B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA77016J1206 competed?
The extent of competition for VA77016J1206 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award